Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trialResearch in context

Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trialResearch in context

Summary: Background: The long-term cancer safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in real-world settings remains unclear, with limited long-term clinical and observational studies. We clarify the long-term cancer risk. Methods: This register-based nationwide emulated trial in...

Full description

Saved in:
Bibliographic Details
Main Authors: Mads Gamborg, Mia Klinten Grand, Kathrine Grell, Susanne Rosthøj, Ulrik Pedersen-Bjergaard, Christian Torp-Pedersen, Lina Steinrud Mørch
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:The Lancet Regional Health. Europe
Subjects:
Glucagon-like peptide-1 (GLP-1) receptor agonists
GLP-1RA
Cancer risk
Long-term sustained use
Duration of use
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776225001383
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items